AMEH
Get informed when a big investor buys or sells
+ FollowUndervalued by 122.4% based on the discounted cash flow analysis.
| Market cap | $1.83 Billion |
|---|---|
| Enterprise Value | $1.44 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.44 |
| Beta | 1.04 |
| Outstanding Shares | 48,853,678 |
| P/E Ratio | 57.58 |
|---|---|
| PEG | 49.76 |
| Price to Sales | 0.57 |
| Price to Book Ratio | 3.71 |
| Enterprise Value to Revenue | 0.41 |
| Enterprise Value to EBIT | -30.58 |
| Enterprise Value to Net Income | 46 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.11 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1591▼ 232.34% |
|---|---|
| Total Calls | 256,500▲ 2150.00% |
| Total Puts | 40,800▲ 44.17% |
Holdings and activity of institutional investors.
| Ownership % | 60.76%▼ 0.56% |
|---|---|
| Total Invested | $733.42M▲ 1.25% |
| Investors Holding | 175▼ 2.00% |
No data
ApolloMed is a leading physician-centric, technology-enabled healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, ApolloMed operates an integrated, value-based healthcar...